As Chinese biotech and pharmaceutical firms gain importance on the global stage, foreign investors from sovereign wealth funds to industry players are securing strategic stakes in their future success. International institutional investors have built up significant positions in Chinese biotech firms over the past decade. These positions often approach, and in some cases exceed, the…
Buildings along Wall Street in New York, US. (Bloomberg) — Wall Street chief executives said investors should brace for an equity market drop of more than 10% in the next 12 to 24 months, and that such a correction may be a positive development. Corporate earnings are strong but “what’s challenging are valuations,” said Mike…
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Warren Buffett‘s public disdain for Bitcoin has not stopped one of his adherents from driving a 94-year-old mutual fund giant’s push into the leading cryptocurrency. Mutual fund manager Capital Group has poured roughly $1 billion into Bitcoin-related…